Pulications

2020

• Xia Q, Zhang H, Zhang P, Li Y, Xu M, Li X, Li X, Dong L. Oncogenic Smurf1 promotes PTEN wild-type glioblastoma growth by mediating PTEN ubiquitylation [published online ahead of print, 2020 Jul 31]. Oncogene. 2020;10.1038/s41388-020-01400-1. doi:10.1038/s41388-020-01400-1

  [Abstract]

• Zhang L, Giuste F, Vizcarra JC, Li X, Gutman D. Radiomics Features Predict CIC Mutation Status in Lower Grade Glioma. Front Oncol. 2020;10:937. Published 2020 Jun 26. doi:10.3389/fonc.2020.00937

  [Abstract] [Full Paper]

• Hui M, Nian J, Wang Z, Li X, Huang C. KDELR2 is an unfavorable prognostic biomarker and regulates CCND1 to promote tumor progression in glioma. Pathol Res Pract. 2020;216(7):152996. doi:10.1016/j.prp.2020.152996

  [Abstract]

• Li C, Zou H, Xiong Z, Xiong Y, Miyagishima DF, Wanggou S, Li X#. Construction and Validation of a 13-Gene Signature for Prognosis Prediction in Medulloblastoma. Front Genet. 2020;11:429. Published 2020 May 19. doi:10.3389/fgene.2020.00429

  [Abstract] [Full Paper]

• Zou H, Li C, Wanggou S, Li X#. Survival Risk Prediction Models of Gliomas Based on IDH and 1p/19q. J Cancer. 2020;11(15):4297-4307. Published 2020 Apr 27. doi:10.7150/jca.43805

  [Abstract] [Full Paper]

• Xiong Z, Yang Q, Li X#. Effect of intra- and inter-tumoral heterogeneity on molecular characteristics of primary IDH-wild type glioblastoma revealed by single-cell analysis [published online ahead of print, 2020 Jun 2]. CNS Neurosci Ther. 2020;10.1111/cns.13396. doi:10.1111/cns.13396

  [Abstract] [Full Paper]

• Yang Q, Xiong Y, Jiang N, Zeng F, Huang C, Li X#. Integrating Genomic Data with Transcriptomic Data for Improved Survival Prediction for Adult Diffuse Glioma. J Cancer. 2020;11(13):3794-3802. Published 2020 Apr 6. doi:10.7150/jca.44032

  [Abstract] [Full Paper]

• Liu H, Yang Q, Xiong Y, Xiong Z, Li X#. Improved Prognostic Prediction of Glioblastoma using a PAS Detected from Single-cell RNA-seq. J Cancer. 2020;11(13):3751-3761. Published 2020 Apr 6. doi:10.7150/jca.44034

  [Abstract] [Full Paper]

• Zhao Z, Yuan X, Yuan J, Cai L, Jiang W, Xie Y, Wanggou S, Zhang C, Tang G, Li H, Peng Z, Li X, Liu Q.. Treatment Strategy for Petroclival Meningiomas Based on a Proposed Classification in a Study of 168 Cases. Sci Rep. 2020;10(1):4655. Published 2020 Mar 13. doi:10.1038/s41598-020-61497-y

  [Abstract] [Full Paper]

• Francisco MA, Wanggou S, Fan JJ, Dong W, Chen X, Momin A, Abeysundara N, Min HK, Chan J, McAdam R, Sia M, Pusong RJ, Liu S, Patel N, Ramaswamy V, Kijima N, Wang LY, Song Y, Kafri R, Taylor MD, Li X#, Huang X#. Chloride intracellular channel 1 cooperates with potassium channel EAG2 to promote medulloblastoma growth. J Exp Med. 2020;217(5):e20190971. doi:10.1084/jem.20190971

  [Abstract] [Full Paper]

• Cao H, Erson-Omay EZ, Li X, Günel M, Moliterno J, Fulbright RK. A quantitative model based on clinically relevant MRI features differentiates lower grade gliomas and glioblastoma [published correction appears in Eur Radiol. 2020 Mar 9;:]. Eur Radiol. 2020;30(6):3073-3082. doi:10.1007/s00330-019-06632-8

  [Abstract]

• Xiong Y, Xiong Z, Cao H, Li C, Wanggou S,Li X#. Multi-dimensional omics characterization in glioblastoma identifies the purity-associated pattern and prognostic gene signatures. Cancer Cell Int. 2020;20:37. Published 2020 Jan 31. doi:10.1186/s12935-020-1116-3

  [Abstract] [Full Paper]

2019

• Chen S, Li X#. [Targeting EGFRvIII for treatment of glioblastoma: Frommolecular mechanisms to clinical strategies]. Zhong Nan Da Xue Xue Bao Yi XueBan. 2019 Nov 28;44(11):1281-1286. doi: 10.11817/j.issn.1672-7347.2019.180643.Chinese. PubMed PMID: 31919324.

  [Abstract] [Full Paper]

• Wang Y, Cheng T, Lu M, Mu Y, Li B, Li X, Zhan X. TMT-based quantitative proteomics revealed follicle-stimulating hormone (FSH)-related molecularcharacterizations for potentially prognostic assessment and personalized treatment of FSH-positive non-functional pituitary adenomas. EPMA J. 2019 Aug29;10(4):395-414. doi: 10.1007/s13167-019-00187-w. eCollection 2019 Dec. PubMed PMID: 31832114; PubMed Central PMCID: PMC6882982.

  [Abstract] [Full Paper]

• Dai S, Yan Y, Xu Z, Zeng S, Qian L, Huo L, Li X, Sun L, Gong Z. Corrigendum:SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis. Front Pharmacol. 2019 Nov 15;10:1358. doi:10.3389/fphar.2019.01358. eCollection 2019. PubMed PMID: 31798454; PubMed CentralPMCID: PMC6874015.

  [Abstract] [Full Paper]

• Yan Y, Xu Z, Chen X, Wang X, Zeng S, Zhao Z, Qian L, Li Z, Wei J, Huo L, Li X,Gong Z, Sun L. Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis.Front Cell Dev Biol. 2019 Oct 2;7:217. doi: 10.3389/fcell.2019.00217. eCollection2019. PubMed PMID: 31632968; PubMed Central PMCID: PMC6783494.

  [Abstract] [Full Paper]

• Ye N, Jiang N, Feng C, Wang F, Zhang H, Bai HX, Yang L, Su Y, Huang C, WanggouS, Li X#. Combined Therapy Sensitivity Index Based on a 13-Gene Signature PredictsPrognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients.J Cancer. 2019 Aug 29;10(22):5536-5548. doi: 10.7150/jca.30614. eCollection 2019.PubMed PMID: 31632497; PubMed Central PMCID: PMC6775685.

  [Abstract] [Full Paper]

• Cao H, Li X, Wang F, Zhang Y, Xiong Y, Yang Q. Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems. Curr Med Chem.2019 Aug 9. doi: 10.2174/0929867326666190809221332. [Epub ahead of print] PubMed PMID: 31400262.

  [Abstract]

• Yi X, Pei Q, Zhang Y, Zhu H, Wang Z, Chen C, Li Q, Long X, Tan F, Zhou Z, Liu W, Li C, Zhou Y, Song X, Li Y, Liao W, Li X, Sun L, Pei H, Zee C, Chen BT.MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy inLocally Advanced Rectal Cancer. Front Oncol. 2019 Jun 26;9:552. doi:10.3389/fonc.2019.00552. eCollection 2019. PubMed PMID: 31293979; PubMed Central PMCID: PMC6606732.

  [Abstract] [Full Paper]

• Qian S, Zhan X, Lu M, Li N, Long Y, Li X, Desiderio DM, Zhan X. Quantitative Analysis of Ubiquitinated Proteins in Human Pituitary and Pituitary Adenoma Tissues. Front Endocrinol (Lausanne). 2019 May 22;10:328. doi:10.3389/fendo.2019.00328. eCollection 2019. PubMed PMID: 31191455; PubMed CentralPMCID: PMC6540463.

  [Abstract] [Full Paper]

• Chang K, Beers AL, Bai HX, Brown JM, Ly KI, Li X, Senders JT, Kavouridis VK,Boaro A, Su C, Bi WL, Rapalino O, Liao W, Shen Q, Zhou H, Xiao B, Wang Y, ZhangPJ, Pinho MC, Wen PY, Batchelor TT, Boxerman JL, Arnaout O, Rosen BR, GerstnerER, Yang L, Huang RY, Kalpathy-Cramer J. Automatic assessment of glioma burden: adeep learning algorithm for fully automated volumetric and bidimensionalmeasurement. Neuro Oncol. 2019 Nov 4;21(11):1412-1422. doi:10.1093/neuonc/noz106. PubMed PMID: 31190077; PubMed Central PMCID: PMC6827825.

  [Abstract] [Full Paper]

• Wu M, Li X, Liu Q, Xie Y, Yuan J, Wanggou S. miR-526b-3p serves as aprognostic factor and regulates the proliferation, invasion, and migration ofglioma through targeting WEE1. Cancer Manag Res. 2019 Apr 11;11:3099-3110. doi:10.2147/CMAR.S192361. eCollection 2019. PubMed PMID: 31114353; PubMed CentralPMCID: PMC6489667.

  [Abstract] [Full Paper]

• Xiong Y, Cao H, Zhang Y, Pan Z, Dong S, Wang G, Wang F, Li X#.Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study. World Neurosurg. 2019 Aug;128:e823-e834. doi:10.1016/j.wneu.2019.04.262. Epub 2019 May 13. PubMed PMID: 31096027.

  [Abstract]

• Yang Q, Li X#. Molecular Network Basis of Invasive Pituitary Adenoma: A Review. Front Endocrinol (Lausanne). 2019 Jan 24;10:7. doi:10.3389/fendo.2019.00007. eCollection 2019. Review. Erratum in: Front Endocrinol (Lausanne). 2019 Sep 24;10:657. PubMed PMID: 30733705; PubMed Central PMCID:PMC6353782.

  [Abstract] [Full Paper]

2018

• Yi X, Guan X, Zhang Y, Liu L, Long X, Yin H, Wang Z, Li X, Liao W, Chen BT,Zee C. Radiomics improves efficiency for differentiating subclinicalpheochromocytoma from lipid-poor adenoma: a predictive, preventive andpersonalized medical approach in adrenal incidentalomas. EPMA J. 2018 Sep21;9(4):421-429. doi: 10.1007/s13167-018-0149-3. eCollection 2018 Dec. PubMedPMID: 30538793; PubMed Central PMCID: PMC6261906.

  [Abstract] [Full Paper]

• Chen X, Wanggou S, Bodalia A, Zhu M, Dong W, Fan JJ, Yin WC, Min HK, Hu M,Draghici D, Dou W, Li F, Coutinho FJ, Whetstone H, Kushida MM, Dirks PB, Song Y, Hui CC, Sun Y, Wang LY, Li X#, Huang X. A Feedforward Mechanism Mediated by Mechanosensitive Ion Channel PIEZO1 and Tissue Mechanics Promotes Glioma Aggression. Neuron. 2018 Nov 21;100(4):799-815.e7. doi:10.1016/j.neuron.2018.09.046. Epub 2018 Oct 18. PubMed PMID: 30344046.

  [Abstract] [Full Paper]

• Wang Z, Yi X, He J, Qing L, Zhou Z, Zhang Y, Zhu Z, Zhou C, Xie H, Li X, Zee C, Chen BT. Catheter-Based Computed Tomography Angiography in Anterolateral ThighPerforator Mapping of Chinese Patients. J Reconstr Microsurg. 2019Mar;35(3):221-228. doi: 10.1055/s-0038-1672129. Epub 2018 Oct 2. PubMed PMID:30278470.

  [Abstract]

• Wu J, Kim C, Bai HX, Tang L, Wang Y, Li X, Zhang Z, Karakousis G, Huang R,Zhang PJ, Xiao B, Yang L. Comparison of Radiation Therapy Alone and Chemotherapy Alone for Low-Grade Gliomas without Surgical Resection. World Neurosurg. 2019Feb;122:e108-e120. doi: 10.1016/j.wneu.2018.09.109. Epub 2018 Sep 24. PubMedPMID: 30261385.

  [Abstract]

• Xiao Y, Karam C, Yi J, Zhang L, Li X, Yoon D, Wang H, Dhakal K, Ramlow P, Yu T, Mo Z, Ma J, Zhou J. ROS-related mitochondrial dysfunction in skeletal muscleof an ALS mouse model during the disease progression. Pharmacol Res. 2018Dec;138:25-36. doi: 10.1016/j.phrs.2018.09.008. Epub 2018 Sep 18. PubMed PMID:30236524; PubMed Central PMCID: PMC6263743.

  [Abstract] [Full Paper]

• Qian S, Yang Y, Li N, Cheng T, Wang X, Liu J, Li X, Desiderio DM, Zhan X.Prolactin Variants in Human Pituitaries and Pituitary Adenomas Identified With Two-Dimensional Gel Electrophoresis and Mass Spectrometry. Front Endocrinol(Lausanne). 2018 Aug 28;9:468. doi: 10.3389/fendo.2018.00468. eCollection 2018.PubMed PMID: 30210449; PubMed Central PMCID: PMC6121189.

  [Abstract] [Full Paper]

• Sang S, Wanggou S, Wang Z, Lin X, Jiang N, Ye N, Li X#. Clinical Long-TermFollow-Up Evaluation of Functional Neuronavigation in Adult Cerebral Gliomas.World Neurosurg. 2018 Nov;119:e262-e271. doi: 10.1016/j.wneu.2018.07.127. Epub2018 Jul 25. PubMed PMID: 30053568.

  [Abstract]

• Huang Y, Chan L, Bai HX, Li X, Zhang Z, Wang Y, Cao Y, Karakousis G, Huang R,Xiao B, Zhang PJ, Yang L. Assessment of care pattern and outcome in hemangioblastoma. Sci Rep. 2018 Jul 24;8(1):11144. doi:10.1038/s41598-018-29047-9. PubMed PMID: 30042517; PubMed Central PMCID:PMC6057968.

  [Abstract] [Full Paper]

• Zou Y, Neale N, Sun J, Yang M, Bai HX, Tang L, Zhang Z, Landi A, Wang Y,Huang RY, Zhang PJ, Li X, Xiao B, Yang L. Prognostic Factors in Clival Chordomas:An Integrated Analysis of 347 Patients. World Neurosurg. 2018 Oct;118:e375-e387. doi: 10.1016/j.wneu.2018.06.194. Epub 2018 Jun 30. PubMed PMID: 29969746.

  [Abstract]

• Yi X, Cao H, Tang H, Gong G, Hu Z, Liao W, Sun L, Chen BT, Li X#. Gliosarcoma:a clinical and radiological analysis of 48 cases. Eur Radiol. 2019Jan;29(1):429-438. doi: 10.1007/s00330-018-5398-y. Epub 2018 Jun 12. PubMed PMID:29948068.

  [Abstract]

• Wang FY, Li XJ#. Angiogenesis in glioma. Glioma 2018;1:43-9

  [Abstract] [Full Paper]

• Tang L, Deng L, Bai HX, Sun J, Neale N, Wu J, Wang Y, Chang K, Huang RY,Zhang PJ, Li X, Xiao B, Cao Y, Tao Y, Yang L. Reduced expression of DNA repairgenes and chemosensitivity in 1p19q codeleted lower-grade gliomas. J Neurooncol. 2018 Sep;139(3):563-571. doi: 10.1007/s11060-018-2915-4. Epub 2018 Jun 19. PubMedPMID: 29923053; PubMed Central PMCID: PMC6697086.

  [Abstract] [Full Paper]

• Ma X, Jin Y, Wang Y, Zhang S, Peng D, Yang X, Wei S, Chai W, Li X, Tian J.Multimodality Molecular Imaging-Guided Tumor Border Delineation and Photothermal Therapy Analysis Based on Graphene Oxide-Conjugated Gold Nanoparticles Chelatedwith Gd. Contrast Media Mol Imaging. 2018 May 7;2018:9321862. doi:10.1155/2018/9321862. eCollection 2018. PubMed PMID: 29853812; PubMed CentralPMCID: PMC5964426.

  [Abstract] [Full Paper]

• Li X, Cao H, Liu Y. Genetic epidemiology and risk factors for brain tumors.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018 Apr 28;43(4):345-353. doi:10.11817/j.issn.1672-7347.2018.04.003. PubMed PMID: 29774869.

  [Abstract] [Full Paper]

2017

• Zeng J, Liu H, Liu L, Liao W, Hu P, Wang X, Li X, Sun L, Zhang Y, Yi X.Fibrosarcoma arising in the paranasal sinus: a clinicopathological andradiological analysis. Dentomaxillofac Radiol. 2018 Jul;47(6):20170459. doi:10.1259/dmfr.20170459. Epub 2018 Apr 23. PubMed PMID: 29658783; PubMed CentralPMCID: PMC6196049.

  [Abstract] [Full Paper]

• Ye B, Stary CM, Li X, Gao Q, Kang C, Xiong X. Engineering chimeric antigen receptor-T cells for cancer treatment. Mol Cancer. 2018 Feb 15;17(1):32. doi:10.1186/s12943-018-0814-0. Review. PubMed PMID: 29448937; PubMed Central PMCID:PMC5815249.

  [Abstract] [Full Paper]

• Wu J, Neale N, Huang Y, Bai HX, Li X, Zhang Z, Karakousis G, Huang R, ZhangPJ, Tang L, Xiao B, Yang L. Comparison of Adjuvant Radiation Therapy Alone andChemotherapy Alone in Surgically Resected Low-Grade Gliomas: Survival Analyses of2253 Cases from the National Cancer Data Base. World Neurosurg. 2018Apr;112:e812-e822. doi: 10.1016/j.wneu.2018.01.163. Epub 2018 Jan 31. PubMedPMID: 29409888.

  [Abstract]

• Dai S, Yan Y, Xu Z, Zeng S, Qian L, Huo L, Li X, Sun L, Gong Z. SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-CateninSignaling Axis. Front Pharmacol. 2018 Jan 4;8:960. doi: 10.3389/fphar.2017.00960.eCollection 2017. Erratum in: Front Pharmacol. 2019 Nov 15;10:1358. PubMed PMID: 29354058; PubMed Central PMCID: PMC5758607.

  [Abstract] [Full Paper]

• Chang K, Bai HX, Zhou H, Su C, Bi WL, Agbodza E, Kavouridis VK, Senders JT,Boaro A, Beers A, Zhang B, Capellini A, Liao W, Shen Q, Li X, Xiao B, Cryan J,Ramkissoon S, Ramkissoon L, Ligon K, Wen PY, Bindra RS, Woo J, Arnaout O,Gerstner ER, Zhang PJ, Rosen BR, Yang L, Huang RY, Kalpathy-Cramer J. ResidualConvolutional Neural Network for the Determination of IDH Status in Low- andHigh-Grade Gliomas from MR Imaging. Clin Cancer Res. 2018 Mar 1;24(5):1073-1081. doi: 10.1158/1078-0432.CCR-17-2236. Epub 2017 Nov 22. PubMed PMID: 29167275;PubMed Central PMCID: PMC6051535.

  [Abstract] [Full Paper]

• Zou Y, Sun J, Zhou Y, Bai HX, Huang X, Babu R, Landi A, Foong KS, Zhang Z,Woo JH, Tao Y, Li X, Tang X, Xiao B, Zhang PJ, Yang L. Prognostic Factors andTreatment of Spinal Astrocytomas: A Multi-institutional Cohort Analysis. Spine(Phila Pa 1976). 2018 May 15;43(10):E565-E573. doi: 10.1097/BRS.0000000000002485.PubMed PMID: 29135884.

  [Abstract]

• Wu J, Zou T, Bai HX, Li X, Zhang Z, Xiao B, Nasrallah M, Karakousis G, Cao Y,Zhang PJ, Yang L. Comparison of chemoradiotherapy with radiotherapy alone for”biopsy only” anaplastic astrocytoma. Oncotarget. 2017 Apr 26;8(40):69038-69046. doi: 10.18632/oncotarget.17441. eCollection 2017 Sep 15. PubMed PMID: 28978179;PubMed Central PMCID: PMC5620319.

  [Abstract] [Full Paper]

• Cao H, Wang F, Li XJ. Future Strategies on Glioma Research: From Big Data to the Clinic. Genomics Proteomics Bioinformatics. 2017 Aug;15(4):263-265. doi:10.1016/j.gpb.2017.07.001. Epub 2017 Aug 7. PubMed PMID: 28797870; PubMed CentralPMCID: PMC5582798.

  [Abstract] [Full Paper]

• Wu M, Wanggou S, Li X, Liu Q, Xie Y. Overexpression of mitochondrial serinehydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas. Onco Targets Ther. 2017 Jul27;10:3781-3788. doi: 10.2147/OTT.S130409. eCollection 2017. PubMed PMID:28794642; PubMed Central PMCID: PMC5538688.

  [Abstract] [Full Paper]

• Xie Y, Wanggou S, Liu Q, Li X, Liu J, Wu M. A brain-specific isoform ofapoptosis-inducing factor 2 attenuates ischemia-induced oxidative stress in HT22 cells. Neurochem Int. 2018 Jan;112:179-186. doi: 10.1016/j.neuint.2017.07.006.Epub 2017 Jul 18. PubMed PMID: 28732772.

  [Abstract]

• Yi X, Xiao D, He Y, Yin H, Gong G, Long X, Liao W, Li X, Sun L, Zhang Y,Zhang B. Spinal Solitary Fibrous Tumor/Hemangiopericytoma: A Clinicopathologicand Radiologic Analysis of Eleven Cases. World Neurosurg. 2017 Aug;104:318-329.doi: 10.1016/j.wneu.2017.05.016. Epub 2017 May 13. PubMed PMID: 28512044.

  [Abstract]

• Jiang N, Wang Z, Chen W, Xie Y, Peng Z, Yuan J, Wanggou S, Su Y, Li X, YuanX. Microsurgical Outcomes After Gross Total Resection on Vestibular Schwannoma in Elderly Patients: A Matched Cohort Study. World Neurosurg. 2017 May;101:457-465. doi: 10.1016/j.wneu.2017.01.120. Epub 2017 Feb 9. PubMed PMID: 28192265.

  [Abstract]

• Wang FY, Kang CS, Wang-Gou SY, Huang CH, Feng CY, Li XJ#. EGFL7 is an intercellular EGFR signal messenger that plays an oncogenic role in glioma.Cancer Lett. 2017 Jan 1;384:9-18. doi: 10.1016/j.canlet.2016.10.009. Epub 2016Oct 8. PubMed PMID: 27725228.

  [Abstract]

Before 2017

• Xiong T, Wanggou S, Li X, Liu Q, Jiang X, Peng Z, Yuan X. [Influence ofpreventive use of vasopressin tannate on diabetes insipidus and serum sodium atthe early postoperation of craniopharyngioma]. Zhong Nan Da Xue Xue Bao Yi XueBan. 2016 Oct 28;41(10):1058-1063. Chinese. PubMed PMID: 27807328.

  [Abstract] [Full Paper]

• Peng F, Li J, Guo T, Yang H, Li M, Sang S, Li X, Desiderio DM, Zhan X. Nitroproteins in Human Astrocytomas Discovered by Gel Electrophoresis and Tandem Mass Spectrometry. J Am Soc Mass Spectrom. 2015 Dec;26(12):2062-76. doi: 10.1007/s13361-015-1270-3. Epub 2015 Oct 8. PMID: 26450359.

  [Abstract]

• Zhan X, Desiderio DM, Wang X, Zhan X, Guo T, Li M, Peng F, Chen X, Yang H, Zhang P, Li X, Chen Z. Identification of the proteomic variations of invasive relative to non-invasive non-functional pituitary adenomas. Electrophoresis. 2014 Aug;35(15):2184-94. doi: 10.1002/elps.201300590. PMID: 24729304.

  [Abstract]

• Wu M, Liu DY, Yuan XR, Liu Q, Jiang XJ, Yuan D, Huang J, Li XJ, Yang ZQ. The expression of moesin in astrocytoma: correlation with pathologic grade and poor clinical outcome. Med Oncol. 2013 Mar;30(1):372. doi: 10.1007/s12032-012-0372-z. Epub 2013 Jan 13. PMID: 23315217.

  [Abstract]

• Huang CH, Li XJ, Zhou YZ, Luo Y, Li C, Yuan XR. Expression and clinical significance of EGFL7 in malignant glioma. J Cancer Res Clin Oncol. 2010;136(11):1737-1743. doi:10.1007/s00432-010-0832-9

  [Abstract]

• Chun-Hai, H. , Xue-Jun LI , & Yi-Zeng, Z. . (2009). Expression of egfl7 in human glioma and its correlation with microvessel density of tumour. Chinese Journal of Otorhinolaryngology-Skull Base Surgery.

  [Abstract]

• Xue-Jun, LI , Xian-Rui, Y. , & Wei-Xi, J. . (2008). Microdissection of the extended transsphenoidal approach. Chinese Journal of Clinical Anatomy.

  [Abstract]

• Xue-Jun, LI , Xian-Rui, Y. , & Shan-Zhi, G. U. . (2008). Imaging anatomy of the extended transsphenoidal approach. Journal of Clinical Research.

• [Abstract]

• Jun H , Xian-Rui Y , Xue-Jun LI# . Surgical approach and histoanatomical features of the oculomotor nerve in cats[J]. Journal of International Neurology and Neurosurgery, 2008.

  [Abstract]